Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
By Cassandra L. Hodgkinson, Christopher J Morrow, Yaoyong Li, R. Metcalf, D. Rothwell, F. Trapani, R. Polanski, D. Burt, K. Simpson, K. Morris and 16 more. Nature Medicine, 2014
685 citations recorded by the source corpus.
Subfields: Epidemiology, Oncology
View Paper: https://www.semanticscholar.org/paper/3486696fb717f7d0ed33223f62a3a585b234c379
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Oncology
Citations in the corpus
- Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments (2022, result): “Similar studies on LC CTC-derived xenografts have provided better insights into therapeutic drug trials, disease prognosis, and resistance mechanisms [84].”
- Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities (2021, methodology): “Ten milliliters of blood collected in EDTA vials was used for isolation of CTCs according to a previously published protocol (Hodgkinson et al., 2014).”
- Liquid biopsy: current technology and clinical applications (2022, methodology): “An alternative method is xenografting by injecting CTCs into immunodeficient mice which has been explored in breast [28, 29], prostate [28], and lung cancer [30].”